Insider Trading: Threshold Pharmaceuticals Inc (THLD.W)
THLD.W on CBOE When Trading NASDAQ Global Select Market
5.52USD
24 May 2013
5.52USD
24 May 2013
Price Change (% chg)
$-0.10 (-1.78%)
$-0.10 (-1.78%)
Prev Close
$5.62
$5.62
Open
$5.49
$5.49
Day's High
$5.55
$5.55
Day's Low
$5.48
$5.48
Volume
900
900
Avg. Vol
2,966
2,966
52-wk High
$9.14
$9.14
52-wk Low
$3.97
$3.97
| FRAZIER HEALTHCARE VI L P | Options Exercised: 0 | ||
| Trade Date: | Monday, 20 Feb 2012 | Price: | 5.38 |
| Title: | Beneficial Owner of More than 10% Class | Shares Held: | 0 |
| Type Traded: | Indirect | Net Change in Shares This Filing: | -13,737,243 |
Institutional Holders
| % Shares Owned: | 74.61% |
| # of Holders: | 125 |
| Total Shares Held: | 42,192,626 |
| 3 Mo. Net Change: | -3,521,323 |
| # New Positions: | 16 |
| # Closed Positions: | 16 |
| # Increased Positions: | 59 |
| # Reduced Positions: | 46 |
| # Net Buyers: | 13 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Harold Selick |
58 | Chief Executive Officer, Director | |
Stewart Kroll |
54 | 2011 | Senior Vice President - Biostatistics and Clinical Operations |
Mark Matteucci |
59 | 2007 | Senior Vice President - Discovery Research |
Joel Fernandes |
43 | 2011 | Vice President - Finance, Controller |
Tillman Pearce |
56 | 2012 | Chief Medical Officer |
Jeffrey Bird |
52 | 2008 | Independent Director |
Bruce Cozadd |
49 | 2005 | Independent Director |
David Hoffmann |
68 | 2007 | Independent Director |
Wilfred Jaeger |
57 | 2001 | Independent Director |
George Parker |
74 | 2004 | Independent Director |
David Parkinson |
62 | 2010 | Independent Director |
Laura Hansen |
IR Contact |

